AIM insider transaction filings
AIM ImmunoTech Inc. — 29 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-16. Screen AIM transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-16 | 4 | Equels Thomas K — CEO & President, Director | Conversion (C): 25,000 @ $0 · Conversion (C): 25 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | CHEMEROW DAVID I. — Director | Conversion (C): 25,000 @ $0 · Conversion (C): 25 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Equels Thomas K — CEO & President | Other (J): 25 (derivative) @ $25,000 · Other (J): 50,000 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | CHEMEROW DAVID I. — Director | Other (J): 25 (derivative) @ $25,000 · Other (J): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | CHEMEROW DAVID I. — Director | Grant/award (A): 2,800 @ $1.23 | EDGAR |
| 2025-07-21 | 4 | KELLNER TED D — Director | Holdings only — no transactions reported | EDGAR |
| 2025-06-16 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 107 @ $7.70 | EDGAR |
| 2025-06-13 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 103 @ $8.70 | EDGAR |
| 2025-04-23 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 1,968,504 @ $0.03 | EDGAR |
| 2025-04-23 | 4 | MITCHELL WILLIAM M — Director | Purchase (P): 196,851 @ $0.03 | EDGAR |
| 2025-04-23 | 4 | KELLNER TED D — Director | Purchase (P): 1,968,504 @ $0.03 | EDGAR |
| 2025-04-07 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 41,000 @ $0.06 | EDGAR |
| 2025-04-04 | 4 | Rodino Peter W III — COO, Secretary, Gen. Counsel | Purchase (P): 500 @ $0.09 | EDGAR |
| 2025-03-18 | 4 | BRYAN NANCY — Director | Grant/award (A): 44,899 @ $0.12 | EDGAR |
| 2025-03-18 | 4 | CHEMEROW DAVID I. — Director | Grant/award (A): 44,899 @ $0.12 | EDGAR |
| 2025-03-18 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 44,899 @ $0.12 | EDGAR |
| 2025-03-06 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 50,000 @ $0.13 | EDGAR |
| 2025-03-05 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 44,000 @ $0.12 | EDGAR |
| 2025-03-04 | 4 | BRYAN NANCY — Director | Grant/award (A): 38,580 @ $0.14 | EDGAR |
| 2025-03-04 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 83,334 @ $0.12 | EDGAR |
| 2025-03-04 | 4 | CHEMEROW DAVID I. — Director | Grant/award (A): 19,290 @ $0.14 | EDGAR |
| 2025-03-04 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 38,580 @ $0.14 | EDGAR |
| 2025-02-20 | 4/A | MITCHELL WILLIAM M — Director | Grant/award (A): 43,330 @ $0.12 | EDGAR |
| 2025-02-20 | 4/A | MITCHELL WILLIAM M — Director | Grant/award (A): 25,797 @ $0.20 | EDGAR |
| 2025-02-20 | 4/A | MITCHELL WILLIAM M — Director | Grant/award (A): 27,412 @ $0.19 | EDGAR |
| 2025-02-19 | 4 | BRYAN NANCY — Director | Grant/award (A): 43,330 @ $0.12 | EDGAR |
| 2025-02-19 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 43,330 @ $0.12 | EDGAR |
| 2025-02-03 | 4 | BRYAN NANCY — Director | Grant/award (A): 25,797 @ $0.20 | EDGAR |
| 2025-02-03 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 25,797 @ $0.20 | EDGAR |
Recent 8-K events — AIM ImmunoTech Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2026-07-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AIM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →